Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 3586 AL 3600

Function and dysfunction of α-synuclein: probing conformational changes and aggregation by single molecule fluorescence

Trexler AJ, Rhoades E.

Mol Neurobiol. 2013 Apr;47(2):622-31. doi: 10.1007/s12035-012-8338-x. Epub 2012 Sep 16.

Psychostimulant effect of levodopa: reversing sensitisation is possible

Castrioto A, Kistner A, Klinger H, Lhommée E, Schmitt E, Fraix V, Chabardès S, Mertens P, Quesada JL, Broussolle E, Pollak P, Thobois SC, Krack P.

J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):18-22. doi: 10.1136/jnnp-2012-302444. Epub 2012 Sep 18.

Foveal vision is impaired in Parkinson's disease

Bodis-Wollner I.

Parkinsonism Relat Disord. 2013 Jan;19(1):1-14. doi: 10.1016/j.parkreldis.2012.07.012. Epub 2012 Sep 19.

Monomorphic ventricular tachycardia 25 years post surgical ablation for Wolff-Parkinson-White

Joza J, Becker G, Pagé P, Essebag V.

Can J Cardiol. 2013 Jan;29(1):130.e7-9. doi: 10.1016/j.cjca.2012.07.011. Epub 2012 Sep 19.

Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis

Dasuri K, Zhang L, Keller JN.

Free Radic Biol Med. 2013 Sep;62:170-185. doi: 10.1016/j.freeradbiomed.2012.09.016. Epub 2012 Sep 19.

Osteoporosis risk and bone mineral density levels in patients with Parkinson's disease: a meta-analysis

Zhao Y, Shen L, Ji HF.

Bone. 2013 Jan;52(1):498-505. doi: 10.1016/j.bone.2012.09.013. Epub 2012 Sep 19.

The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders

McIntyre RS, Powell AM, Kaidanovich-Beilin O, Soczynska JK, Alsuwaidan M, Woldeyohannes HO, Kim AS, Gallaugher LA.

Behav Brain Res. 2013 Jan 15;237:164-71. doi: 10.1016/j.bbr.2012.09.021. Epub 2012 Sep 20.

The unravelling of metabolic dysfunctions linked to metal-associated diseases by blue native polyacrylamide gel electrophoresis

Han S, Auger C, Castonguay Z, Appanna VP, Thomas SC, Appanna VD.

Anal Bioanal Chem. 2013 Feb;405(6):1821-31. doi: 10.1007/s00216-012-6413-9. Epub 2012 Sep 22.

Optogenetic investigation of neuropsychiatric diseases

Huang F, Tang B, Jiang H.

Int J Neurosci. 2013 Jan;123(1):7-16. doi: 10.3109/00207454.2012.728651. Epub 2012 Oct 16.

Composite brains: toward a systems theory of neural reconstruction

Polgar S.

Cell Transplant. 2013;22(3):381-91. doi: 10.3727/096368912X656072. Epub 2012 Sep 21.

Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease

Sriram A, Ward HE, Hassan A, Iyer S, Foote KD, Rodriguez RL, McFarland NR, Okun MS.

J Neurol. 2013 Feb;260(2):521-7. doi: 10.1007/s00415-012-6669-1. Epub 2012 Sep 25.

Scrub typhus associated with transient parkinsonism and myoclonus

Chiou YH, Yang CJ, Lai TH.

J Clin Neurosci. 2013 Jan;20(1):182-3. doi: 10.1016/j.jocn.2012.01.047. Epub 2012 Sep 23.

Toxoplasmosis and neuropsychiatric diseases: can serological studies establish a clear relationship?

Fabiani S, Pinto B, Bruschi F.

Neurol Sci. 2013 Apr;34(4):417-25. doi: 10.1007/s10072-012-1197-4. Epub 2012 Sep 26.

Oxygen consumption, oxygen cost, heart rate, and perceived effort during split-belt treadmill walking in young healthy adults

Roper JA, Stegemöller EL, Tillman MD, Hass CJ.

Eur J Appl Physiol. 2013 Mar;113(3):729-34. doi: 10.1007/s00421-012-2477-7. Epub 2012 Aug 30.

Fiddling with the pacemaker: Twiddler's syndrome in a Parkinsonian patient

Grapsa J, Koa-Wing M, Fox KF.

Perfusion. 2013 Jan;28(1):31-3. doi: 10.1177/0267659112461161. Epub 2012 Sep 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias